THE LIFESCIENCE CONSULTING COMPANY
We specialise in securing grant funding for R&D projects in biotechnology, pharmaceuticals, medical and environmental technology and IT for life sciences.
Our expertise helps companies and research institutions unlock financing opportunities driving innovation and growth.
We specialise in securing German grants including KMU innovative and ZIM, as well as European funding from Horizon Europe, such as EIC accelerator and EIC transition and others.
This is how we support our clients:
ConsulTech GmbH has received funding a) from the European Union's Horizon Europe research and innovation programme under Grant Agreement No 101137311 for the project APPEAL; b) for the project BeeGuards (GA No 101082073), c) from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 673737 for the project GLIOMARK, d) from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 777500 for the project IMI-PainCare.
ConsulTech GmbH has been funded by the German Ministry of Economy Affairs and Climate Action (BMWK) via the ZIM grant programme with a research idea relating to new therapies for brain tumours (grant number: 16KN073267).
The "Gliotar"-project of ConsulTech is being funded by the German Ministry for Education and Research (grant number: 16GW0310K).